Author name: Leonardo Arias

Insurers plan to keep sacrificing MA growth for profitability next year, after second quarter results for Humana and CVS showed the success of the strategy.

One vaccine expert called the move, which cancels some $500 million in messenger RNA research contracts, a “giant step backward for science.” 

The German giant has already trimmed more than 10,000 employees since initiating a massive restructuring initiative in July 2023. Bayer said even more cuts are coming as it weathers up-and-down sales across its portfolio.

Maziar Mike Doustdar, who was named as Novo Nordisk’s new CEO last week, spoke on a second quarter earnings call of reallocating resources to the company’s “main core” of metabolic disease.

Dually classifying allows urban facilities to benefit from rural health programs, even as many rural facilities struggle financially and are at high risk of closure, researchers wrote.

Terns, once a rising star in obesity and the MASH space, will refocus on cancer and partner out a handful of obesity assets.

En un avance hacia la sostenibilidad energética y agrícola, unos investigadores han demostrado que los módulos fotovoltaicos reutilizados pueden integrarse eficazmente en sistemas agrivoltaicos, ya que mantienen un rendimiento lo bastante estable.   Los sistemas agrivolta …

Este año, el lema del Día Mundial de los Océanos (8 de junio) fue “Maravillas oceánicas: conservar lo que nos sostiene” (“Wonder, sustaining what sustains us” en la web oficial). Con él, se ha querido señalar el asombro (otra acepci&oa …

The Department of Health and Human Services is terminating around $500 million in BARDA contracts associated with mRNA vaccine development, a move that will affect several pharma companies, including Moderna, Pfizer, Sanofi and AstraZeneca.

BioNTech also laid off 63 employees in June in conjunction with the discontinuation of its cell therapy manufacturing operations in Gaithersburg, Maryland.